Not sure why they need the higher dose, seems to be working fine. Will establish an excellent safety profile though.
Yes, it seems close enough. And yes, it has been a nightmare. My break even is around 16, I'd like to get closer, but we will see.
Funny, but not true. I am pretty sure those guys at least have green cards and work visas.
They've put off the meeting so they can be sure to issue another 5 billion shares. I would wait until .00005 before I made my big move.
I checked Morningstar, the data is only as of 12/31/2014. I think it's important to pay attention to both institutions and funds. If you add them all up it comes to 45.28% owned by funds and institutions, and most have increased their positions as of 12-31-2014
TD Ameritrade shows 32.52% institutional ownership, up quite a bit from the 10% shown a few months ago.
9 million shares is about $2,100.00. I think the MM pass the stock back and forth to make it look like something is happening. Another 5 billion shares will most likely be authorized. I don't really see how anybody in their right mind could see anything of value here. It's entertaining to see what the scamming pumpers have to say, usually good for a laugh. You don't really believe any of that, do you?
The patent expires in 2019, there is not nearly enough time to develop the drug and run the Phase IIb and Phase III trials. Phase IIa was run by Amarin before the license. Nice deceptive subject line, clearly part of the scam. Yet another extremely optimistic press release by MCET.
"MultiCell estimates MCT-125 could generate up to $3 billion in cumulative worldwide sales during the time MCT-125 is under patent protection"
There will be no trials.
Thank you for your condescension. I stand corrected, phase II, and moving to stage 2 and enrolling more patients. I think the fact that there are patients still alive speaks volumes about the efficacy.
"We are encouraged by the data to date and are looking forward to moving to the second stage of enrollment and completion of the GOG 0265 study. Stage 1 patients that are still alive will continue to be followed for survival."
I just thought it was unusual to mention efficacy as part of a Phase I trial, they are usually just looking at safety.
I don't see any specific information on efficacy? Is it in there or somewhere else?
How ya doing Bobby? Booked nice profit on ADXS, but knew the science and company was too strong, and popped back in big time. Didn't pick the bottom but very happy. I know you don't understand such things as basic science, that's why you lie and pick scams like MCET. Good luck!
Their strategy is to just post so much nonsense that you can't even find the real posts. Good luck with that.